These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9805978)

  • 21. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates.
    Schäfer SA; Hansen BC; Völkl A; Fahimi HD; Pill J
    Biochem Pharmacol; 2004 Jul; 68(2):239-51. PubMed ID: 15193996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 26. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypolipidemic drugs and diabetes mellitus].
    Bláha V; Mistrík E
    Vnitr Lek; 2009 Apr; 55(4):357-62. PubMed ID: 19449750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New strategies in the treatment of dyslipidemia: do we know how?
    Vrablík M; Ceska R
    Semin Vasc Med; 2004 Aug; 4(3):305-10. PubMed ID: 15630630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):62-9. PubMed ID: 17924453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacology of hypolipidemic agents].
    Féry F; Balasse EO
    Rev Med Brux; 1997 Feb; 18(1):26-31. PubMed ID: 9132914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of insulin sensitizers in diabetes.
    Jawa A; Fonseca V
    Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Specific treatment of primary hyperlipoproteinemia in diabetes mellitus].
    Mincou I; Străchinariu R; Georgesco M
    Med Interne; 1979; 17(2):163-8. PubMed ID: 472638
    [No Abstract]   [Full Text] [Related]  

  • 34. [Criteria for the choice of antidiabetic treatment].
    Parodi FA
    Clin Ter; 1969 Feb; 48(4):379-86. PubMed ID: 5355894
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs.
    Sirois C; Moisan J; Poirier P; Couture J; Gregoire JP
    Age Ageing; 2009 Nov; 38(6):741-5. PubMed ID: 19759258
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diabetes: current problems].
    Boukhris R
    Tunis Med; 1971; 4():201-9. PubMed ID: 4946487
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral antidiabetic drugs].
    Aarseth S
    Tidsskr Nor Laegeforen; 1971 Nov; 91(17):1330-6. PubMed ID: 4935814
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypoglycemic sulfamides and biguanides].
    Curchod B
    Schweiz Rundsch Med Prax; 1971 Jan; 60(3):83-6. PubMed ID: 5549862
    [No Abstract]   [Full Text] [Related]  

  • 39. [Our experiences with butyl-biguanide, a new Hungarian oral antidiabetic].
    Halmos T; Loczka B; Salamon F
    Orv Hetil; 1966 Oct; 107(41):1938-9. PubMed ID: 5978536
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperlipemias in diabetics].
    Mirouze J; Carty ME
    Coeur Med Interne; 1974; 13(4):613-26. PubMed ID: 4465060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.